Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-Aggrus monoclonal antibody, domain in Aggrus which is required for binding to CLEC-2, and method for screening for Aggrus-CLEC-2 binding inhibitor

Anti-Aggrus monoclonal antibody, domain in Aggrus which is required for binding to CLEC-2, and method for screening for Aggrus-CLEC-2 binding inhibitor

US Patent 10730939 · Granted Aug 4, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oxadiazoline compound or salts thereof, agricultural and horticultural fungicide2025
Oxadiazole compounds or salts thereof, agrohorticultural fungicides containing t2024
Method for manufacturing semiconductor device and substrate processing apparatus2024
Fusions and method for detecting same2024
Oxadiazoline compounds or salts thereof, agrohorticultural fungicides containing2024
Method for forming silicon film and processing apparatus2023
Anti-PD-L1 antibody for detecting PD-L12023
Film forming method and film forming apparatus2023
Anti-podoplanin antibody2022
Therapeutic agent for lung cancer that has acquired EGFR-TKI resistance2022
Heat insulation structure at lower end of vertical heat treatment apparatus and 2022
Film forming method and film forming apparatus2022